Zenotech Laboratories standalone net profit declines 10.42% in the June 2024 quarter

Zenotech Laboratories standalone net profit declines 61.77% in the December 2022 quarter

Bajaj Finance, Vedanta, Aarti Drugs, Aditya Birla Sun Life AMC, CMS Info Systems, Glenmark Life Sciences, Godfrey Phillips India, Sterlite Technologies, Zenotech Laboratories, and AIA Engineering are scheduled to announce their earnings today

Stocks to Watch: Adani Enterprises, Bajaj Finance, Maruti Suzuki, Tata Motors

Zenotech Laboratories standalone net profit rises 191.58% in the September 2022 quarter

Zenotech Laboratories standalone net profit rises 7.71% in the June 2022 quarter

Zenotech Laboratories standalone net profit rises 5057.14% in the December 2021 quarter

Zenotech Laboratories reports standalone net profit of Rs 0.95 crore in the September 2021 quarter

Zenotech Laboratories reports standalone net profit of Rs 3.50 crore in the June 2021 quarter

Zenotech Laboratories reports standalone net profit of Rs 1.18 crore in the March 2021 quarter

Zenotech Laboratories standalone net profit declines 98.98% in the December 2020 quarter

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio primarily serves therapy areas, such as oncology and anesthesiology.